ATP 4-02.84 governs the treatment of biological warfare agent casualties through multi-service tactics, techniques, and procedures.
View ATP 4-02.84 on armypubs.army.mil
It addresses biological warfare agents, recognition, bacterial and viral agents, toxin agents, identification technologies, and specimen collection, handling, and transport. It sets out ten steps in the management of biological casualties on the battlefield and includes medical management and treatment in biological warfare operations.
Biological warfare attacks have the potential to create mass casualty situations; that is, any large number of casualties produced in a relatively short period of time that exceeds the local medical support capabilities for their care. (paragraph 1-81)
Bacteria generally cause disease in human beings and animals by one of two mechanisms: invasion (infection) of host tissues with propagation there and production of poisons (toxins) that destroy or disrupt host tissues. (paragraph 3-1)
Medical personnel have the primary responsibility for collecting and testing clinical specimens (for example, human blood, tissue, urine, and sputum) for BW agents. (paragraph 6-25)
The Laboratory Response Network is an early warning network to detect the covert use of pathogenic agents. (paragraph 6-24)
Level A laboratories have minimal agent identification capabilities. Their primary role is to rule out and refer to their nearest Level B laboratory. (paragraph 6-25)